24小时热门版块排行榜

返回列表

当前主题已经存档。

当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖

yensh

金虫 (文坛精英)

ACI: 1
应助: 0 (幼儿园)
贵宾: 7.448
金币: 2333.1
散金: 18967
红花: 118
沙发: 677
帖子: 25063
在线: 1871.6小时
虫号: 446925
注册: 2007-10-28
专业: 未来学

[交流] 【国际通缉令——国外分析专业名师征集】

国际通缉令

【活动目的】

希望大家介绍自己收集到的国外（特别是欧美地区）分析化学专业名师；
方便各位立志出国深造的朋友们予以参考！

【活动方式】
跟帖参加活动

引用回帖:

跟帖格式
【导师

(请提供准确信息，若不清楚请留空)

【奖励方式】
视信息量给予3-10个金币奖励
(信息获取较为困难，提高奖励数，绝无崇外之意！)

【特别鸣谢】谢谢虫友littlewing2007提议！

特别提醒：此贴是国外分析导师信息贴！
此外，我们不能保证信息的完全准确！

[ Last edited by yensh on 2008-1-5 at 21:32 ]

回复此楼

» 猜你喜欢

ID已经更换，此ID作废

1楼 2007-12-29 10:57:35

已阅回复此楼关注TA 给TA发消息送TA红花 TA的回帖

weihui_cn

金虫 (职业作家)

ACI: 2
应助: 3 (幼儿园)
贵宾: 0.05
金币: 912.1
散金: 3292
红花: 37
帖子: 3342
在线: 319.1小时
虫号: 466106
注册: 2007-11-23
专业: 电化学分析

Nie Shuming聂书明

★ ★ ★ ★ ★ ★
wingcat(金币+6,VIP+0):谢谢提供信息~~~

http://www.wcigtccne.com/investigatorsdetail.php?id=5

较早涉猎单分子检测

Shuming Nie, Ph.D.

Wallace H. Coulter Distinguished Chair in
Biomedical Engineering at Emory and Georgia Tech
Professor of Biomedical Engineering, Chemistry,
Hematology & Oncology
Director for Nanotechnology and Bioengineering,
Winship Cancer Institute

Shuming Nie is one of the world's leaders in detecting single molecules in biological systems -- the science of nanotechnology. He is one of the first scientists in the world to utilize nanotechnology, which has been used in manufacturing for many years, in the biomedical field. Dr. Nie has been invited by the Nobel Foundation and other international centers to describe his research on nanotechnology and the ability to make measurements of molecules in single cells and in trace amounts of biological material. This research has tremendous potential for cancer diagnostics, and monitoring treatment effects in tiny clinical biopsies.

The National Cancer Institute (NCI) of the National Institutes of Health recently selected Emory University and the Georgia Institute of Technology as one of seven National Centers of Cancer Nanotechnology Excellence (CCNE). The new center will be named the "Emory-Georgia Tech Nanotechnology Center for Personalized and Predictive Oncology," and will be housed in Emory's Winship Cancer Institute and on the Georgia Tech campus. The amount awarded is $3.66 million for the first year, and is expected to reach $19-20 million over a five-year period.

Earlier, the NIH awarded Dr. Nie and his colleagues' two new collaborative research grants totaling nearly $10 million. The grants will be used to establish a multidisciplinary research program in cancer nanotechnology and to develop a new class of nanoparticles for molecular and cellular imaging.

In each of these grants, investigators are working at the sub-atomic level, seeking data that will link molecular signatures, (underlying molecular features) to patients' clinical outcomes so that cancers can be predicted, detected earlier and treated more effectively. The research will have broad applications to many types of tumors, including prostate, breast, colorectal cancer and lymphoma.

In addition, Dr. Nie and his team will collaborate with cell biologists to study a variety of molecules involved in the development and progression of cancer, including those involved in programmed cell death; genes such as the p53 gene, which is implicated in many kinds of cancer; and microtubules and molecular motors, which are involved in transporting the proteins in cells that regulate cell growth.